Resources

Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

INCIDENCE AND EPIDEMIOLOGY Anal cancer is a rare disease that accounts for <1% and <3% of all new cancer diagnoses and gastrointestinal tumours, respectively. The most common histological subtype is squamous-cell carcinoma of the anus (SCCA) with an annual incidence of 0.5-2.0 in 100 000.1

ACPGBI EDI Statement

The Association of Coloproctology of Great Britain and Ireland (ACPGBI) would like to acknowledge and recognise the importance of the independent review of diversity and inclusion carried out by Baroness Helena Kennedy QC for the Royal College of Surgeons of England (RCS England).

Bowel Cancer Screening Programme Pathology Guidelines

BSG guidelines on inflammatory bowel disease biopsies

Dukes Club: Young Consultants Session - The Consultant Interview

Bowel cancer screening programme - guidance on reporting lesions

Patients Used in Analysis

A flowchart illustrating the filtering, inclusion and exclusion of patient records in the Audit.

The Association of Coloproctology of Great Britain & Ireland Clinical Governance Board Statement on Consent – Updated October 2020

The Clinical Governance Board would like to remind Association members of the principles of consent, especially for high-risk procedures. A patient-centred approach should be adopted, following the principles laid out in the recently updated GMC guidance on decision making and consent.

Royal College of Pathology Dataset for histopathological reporting of carcinomas and mucinous neoplasms of the appendix

South West Chapter meeting 2 March 2021

South West Chapter Meeting